Next |
home / stock / rnugf / rnugf message board
Subject | By | Source | When |
---|---|---|---|
ReNeuron : Appointments to Scientific Advisory Board | georgejjl | investorshub | 08/23/2019 11:50:20 AM |
Edited Transcript of RENE.L earnings conference call or | georgejjl | investorshub | 07/12/2019 11:44:29 AM |
Well that was an anti-climax. | Spideyboy | investorshub | 07/12/2019 4:43:51 AM |
ReNeuron wins Breakthrough of the Year Award | georgejjl | investorshub | 07/12/2019 2:16:27 AM |
Sold$ RNUGF shares today to buy more $AVXL shares. | georgejjl | investorshub | 07/11/2019 11:55:01 PM |
NEWS!!! hRPC for retinal disease | georgejjl | investorshub | 07/11/2019 10:07:24 AM |
Will there be more buying of this stock | georgejjl | investorshub | 07/10/2019 4:03:19 AM |
NEWS on Thursday July 11, 2019 | georgejjl | investorshub | 07/08/2019 11:38:42 PM |
No news. No insider buys. No instit buyers? | JUST 10-11-12 | investorshub | 07/04/2019 3:39:57 PM |
Just 7 calendar days from NEWS on Thursday | georgejjl | investorshub | 07/04/2019 11:51:33 AM |
NEWS within 2 weeks from TODAY June 27, 2019 | georgejjl | investorshub | 06/27/2019 10:52:33 AM |
Target is five, but who knows. Got | JUST 10-11-12 | investorshub | 06/21/2019 8:23:51 PM |
Time to buy | JUST 10-11-12 | investorshub | 06/21/2019 8:03:39 PM |
ReNeuron wins Breakthrough of the Year Award | georgejjl | investorshub | 06/19/2019 2:04:53 AM |
ReNeuron Group plc (AIM: RENE), a UK-based global | georgejjl | investorshub | 06/19/2019 1:53:31 AM |
ReNeuron Group ($RNUGF) Lifted to Buy at Zacks | georgejjl | investorshub | 06/08/2019 12:31:34 AM |
A video from 2017 with good descriptions of | georgejjl | investorshub | 06/01/2019 4:03:37 AM |
ReNeuron Group plc | georgejjl | investorshub | 06/01/2019 12:51:46 AM |
Thanks | JUST 10-11-12 | investorshub | 05/21/2019 12:29:45 AM |
I expect $10.00 or more per share before | georgejjl | investorshub | 05/21/2019 12:15:28 AM |
News, Short Squeeze, Breakout and More Instantly...
ReNeuron Group Company Name:
RNUGF Stock Symbol:
OTCMKTS Market:
(NewsDirect) ReNeuron Group PLC executive chairman Iain Ross tells Proactive that the company is focused on generating in vivo data and validating its exosome delivery technology platform CustomEX as 2023 gets underway. ReNeuron will conduct head-to-head studies with its competitors to pr...
LONDON, UK / ACCESSWIRE / October 10, 2022 / ReNeuron Group, a stem cell-derived exosome technology company, has presented encouraging preclinical data highlighting the enhanced drug delivery capability of its customisable exosome platform (CustomEx) over conventional human embryonic kidney-...
LONDON, UK / ACCESSWIRE / October 11, 2021 / ReNeuron has announced that the nine-patient Phase IIa (2m cell dose) extension study (halted in June after a presumed eye infection case) has fully restarted with five patients left to treat. Two patients are scheduled for treatment in October. T...